
How A New Wave Of Defence Spending Is Helping Climate Innovators
Why National Security Spending Might Be the Unexpected Ally of Climate Tech
As global powers escalate military spending, climate advocates are sounding the alarm: could this defence-first posture stall momentum for green innovation? Not necessarily, argues Ally LaTourelle Whitney, founder of the Government Affairs Accelerator. For her, the answer isn't retreat — it's realignment.
'National security and sustainability are no longer separate conversations,' she says. 'What we're seeing is not a full redirection of funding, but a diversification of portfolios.'
And the numbers suggest just how serious the global defence pivot has become. In 2023, the United States passed a record $858 billion defence budget. Germany committed €500 billion to military and infrastructure upgrades. Japan approved its largest postwar defence package. With the war in Ukraine and broader geopolitical tensions continuing to unsettle global markets, defence spending is surging.
But LaTourelle Whitney — who also advises America 2030, a $50 million growth-stage fund investing in dual-use technologies — sees a deeper opportunity. Technologies that address both security and climate needs are gaining traction, and the once-clear line between the two sectors is blurring fast.
A trained lawyer with experience spanning public policy, finance, and science, LaTourelle Whitney has long operated across sectors. Today, she's at the forefront of a new wave of investors backing 'dual-use' innovation — technologies that serve both military and civilian purposes.
'Lightweight composites, autonomous systems, low-emission fuels — these aren't just military tech,' she explains. 'They're also the building blocks of sustainable infrastructure.'
Whitney points out that many modern defence innovations, by necessity, are greener than their predecessors. 'Defence tech is lightweight, electric, reusable — and increasingly dual-use. Consider field-deployable solar panels or autonomous drones designed to reduce fuel-heavy operations. These are defence-first, but they're also climate-supportive.'
The U.S., EU, and Asia have been increasing defence budgets while simultaneously issuing mandates for greener military operations — from logistics to procurement. These dual pressures are accelerating the convergence of sustainability and security in innovation.
Climate tech is now intertwined with strategic concerns like energy independence and infrastructure resilience. A 2022 report by the International Military Council on Climate and Security called climate change a 'threat multiplier,' exacerbating everything from conflict and migration to economic instability.
'As defence tech becomes more sustainability-conscious, there's growing legitimacy for climate considerations within historically conservative procurement channels,' says LaTourelle Whitney.
Examples of this shift are already emerging. The Pentagon has issued calls for field-deployable solar panels and autonomous systems to reduce reliance on vulnerable fuel supply chains. NATO's Defence Innovation Accelerator for the North Atlantic (DIANA), launched in 2023, is funding startups that deliver both operational efficiency and environmental value — from robotics to energy-generating textiles.
Meanwhile, companies like Crusoe — which captures flare gas from oil fields and converts it into power for data centres — are demonstrating how climate solutions can have direct applications for edge computing and battlefield energy needs.
'There's a new generation of investors who no longer see sustainability and security as separate lanes,' says LaTourelle Whitney. 'They're thinking holistically — about how technology reduces conflict risk, resource dependence, and geopolitical instability. That's fuelling support for what some now call 'peace tech.''
Despite continued growth in climate tech investment, the capital is shifting toward solutions that serve infrastructure, resilience, and supply chain security.
'Pure-play consumer green tech may feel the squeeze,' LaTourelle Whitney cautions. 'Especially if it lacks ties to critical systems.'
Her advice to climate-focused founders? Speak the language of strategic value. 'Can your technology operate off-grid? Does it reduce reliance on foreign-sourced materials? Can it serve disaster zones or conflict environments? If yes, you've got a compelling pitch.'
She also encourages climate tech entrepreneurs to explore non-traditional funding paths. Agencies like DARPA or NATO's DIANA, public-private partnerships, and government procurement programmes offer alternatives to venture capital that may be more aligned with the moment.
'Don't just think VC,' she adds. 'Think procurement, think policy, think long-term geopolitical relevance.'
The strategic pivot toward dual-purpose technology is already taking hold in national policy. The war in Ukraine, pandemic-era supply chain shocks, and rising concerns over technological sovereignty have pushed governments to reconsider their priorities.
'We're seeing a real shift — mandates for greener defence logistics, sustainable materials like biobased nylons, and remote technologies that support humanitarian and military operations alike,' LaTourelle Whitney says.
And climate tech is well-positioned — if it adapts. 'Being green won't be enough,' she concludes. 'But being green, resilient, and strategically relevant? That's a winning formula.'
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
9 minutes ago
- Yahoo
UnitedHealth Stock Is One of the Worst-Performing S&P 500 Stocks in 2025. Should You Buy the Dip?
Wall Street is cheering fresh highs as the S&P 500 Index ($SPX) wraps a solid second quarter, closing June 2025 strong. The rally has been powered by cooling inflation, resilient earnings, and fading tariff concerns after April's policy shock. Just three months back, the market briefly dipped toward bear territory amid geopolitical tensions, China's AI push, tariff fears, and fiscal uncertainty, keeping investors on edge about the rebound's staying power. Despite the S&P rallying over 28% from its April lows of $4,835, the bull run has still left many big names behind. Nearly a third of the index's stocks still ended the first half of 2025 in the red. UnitedHealth (UNH), a giant in health insurance and managed care services, has plunged 39% so far in 2025. UNH stock has been hit by soaring Medicare Advantage costs, a probe into Medicare fraud, and a sudden CEO exit, making it the index's fourth-worst performer. Michael Saylor Says 'You'll Wish You'd Bought More' Bitcoin as MicroStrategy Doubles Down Is Microsoft Stock About to Go Nuclear? Is Super Micro Computer Stock a Buy, Sell, or Hold for July 2025? Tired of missing midday reversals? The FREE Barchart Brief newsletter keeps you in the know. Sign up now! While UNH is at five-year lows, a 1.8% five-day bounce hints at some life. With the dividend-paying stock halved and trading at a compelling valuation, is this a classic 'buy the dip' setup? Or a moment for caution despite the allure of value and yield? Founded in 1977, UnitedHealth has grown into a $295 billion healthcare heavyweight. With its deep roots in health insurance and care services, the company runs on two powerhouse engines: UnitedHealthcare and Optum. UnitedHealthcare handles the insurance side, offering plans that serve over 50 million people. It's the backbone, giving the company scale, reach, and reliable revenue. But it's Optum that brings the spark, driving growth through data, tech, and pharmacy solutions. From analytics to care delivery, Optum's strategy pushes innovation across the system. Together, these segments give the company its edge in a complex healthcare landscape. UNH stock has been in free fall in 2025, hitting a low of $248.88 in May. Over the past 52 weeks, the stock has declined 38%, trailing far behind the broader S&P's surge of 13%. However, UNH stock is rebounding, up 1% over the past month. UnitedHealth's downfall in 2025 was not just a single bad headline. It was a chain reaction that started fast and spiraled hard. It kicked off on April 17, when the company shocked the Street by slashing its full-year earnings forecast. This was because a flood of higher-acuity Medicare Advantage patients drove costs far beyond expectations, exposing just how outdated and fragile their forecasting models had become. Then May hit like a wrecking ball. CEO Andrew Witty abruptly resigned, raising eyebrows amid growing pressure. Days later, reports surfaced of a U.S. Department of Justice investigation into alleged Medicare fraud. By mid-May, the stock had crashed, hitting five-year lows. Just when it seemed the damage was done, more scandal dropped with accusations of UnitedHealth secretly paying nursing homes to avoid costly hospital transfers. Even insider buying gave only a brief lift to UNH. In a short span, UnitedHealth went from a rock-solid name to a cautionary tale unraveling in real time. After its brutal springtime plunge, UNH stock is priced at 14 times forward earnings and 0.7 times sales, trading in bargain territory. Those multiples sit well below both the sector medians and its own five-year averages, catching the eye of value hunters sniffing out a possible rebound. Despite the stock's decline, UnitedHealth has signaled some confidence where it counts: dividends. In June, the company hiked its quarterly payout by 5.2% to $2.21, marking 15 consecutive years of increases. Paid out on June 24, the hike pushed its annual yield near 2.6%. On April 17, UnitedHealth reported Q1 2025 earnings, and it wasn't the kind of update Wall Street wanted to hear. Revenue climbed 9.8% year-over-year (YOY) to $109.6 billion but still came in shy of expectations. Adjusted EPS rose 4.2% to $7.20 yet missed the estimated mark of $7.27. UnitedHealthcare, the insurance arm, posted a solid 12.2% revenue gain to $84.6 billion. Meanwhile, Optum saw more modest growth of 4.6% to $63.9 billion, with Optum Rx doing the heavy lifting. Still, rising costs loomed large. Total operating expenses surged 9.4% annually to $100.5 billion. On the brighter side, the company exited the quarter with $34.3 billion in cash and short-term investments and generated $5.5 billion in operating cash flow. Shareholders weren't left in the cold either, with over $5 billion returned through buybacks and dividends. UnitedHealth's steep selloff wasn't just about Q1 results. It was the guidance cut that really rattled sentiment. Management slashed its 2025 adjusted EPS outlook to between $26 and $26.50, down from the initially forecast range of $29.50 to $30 in December 2024 and below fiscal 2024 adjusted EPS of $27.66. Surging Medicare Advantage costs and shifts in Optum's patient mix have taken a real bite. Now, all eyes are on the fiscal Q2 report, expected to be released on July 29 before the market opens. Analysts forecast the Q2 bottom line to be around $5.08 per share, down 25% YOY. Looking to fiscal 2025, adjusted EPS is expected to decline 20% annually to $22.07, then surge by 15% to $25.39 in fiscal 2026. Last Wednesday, UBS reiterated its 'Buy' rating on UNH stock but trimmed the price target to $385 from $400. The cut followed CEO Stephen Hemsley's cautious tone at the June 2 meeting, hinting at more conservative 2025 guidance. UBS anticipates fiscal 2025 EPS closer to $20, down from the earlier $22.50 consensus. Margins were also revised, with Medicare Advantage trimmed to 1.5% and Optum Health lowered to 4.5%. Despite the recent shakeups, Wall Street hasn't completely hit the panic button yet. Last month, UnitedHealth shook things up by axing broker commissions on select Medicare Advantage plans — a move aimed at trimming the cost that forced it to yank full-year guidance. Hightower Chief Investment Strategist Stephanie Link called it a smart pivot, saying the same issue 'got them in trouble' to begin with. Link is bracing for short-term volatility but stays bullish long-term, calling UNH stock 'too cheap' for a top-tier name in the industry. There's still optimism in the air, but with a touch of caution. UNH stock has a 'Moderate Buy' consensus overall, down from a consensus 'Strong Buy' rating a month ago. Of the 24 analysts covering the stock, 15 advise a 'Strong Buy,' two suggest a 'Moderate Buy,' and seven analysts play it safe with a 'Hold.' The mean price target of $363.43 implies shares could rise as much as 18%. The Street-high target of $440, way below this year's highs, signals that UNH has an upside potential of 43% from current levels. The U.S. healthcare industry, despite constant political firestorms, is built to endure. For years, UnitedHealth has stood as its crown jewel. Defensive, dividend-paying, and shock-resistant, it has been the kind of stock long-term investors can count on. But 2025 has shattered that illusion. While the broader market climbs to record highs, UnitedHealth's dramatic plunge reminds us that even giants can stumble hard. Sure, UNH stock now trades at a discount, offering an attractive dividend yield. Insiders are buying shares, and UnitedHealth still commands significant market share and robust cash flow. But is this really a 'buy the dip' moment? It's probably a bet that management can steady the ship, and the storm eventually clears. Until then, UnitedHealth sits in a gray zone between legacy and uncertainty, where long-term promise collides with short-term pain. Investors should exercise caution before jumping in. On the date of publication, Sristi Suman Jayaswal did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
9 minutes ago
- Yahoo
Prologis (PLD) To Add 4000 Homes with Caltrain Site Revamp
Prologis, Inc. (NYSE:PLD) is one of the most undervalued stocks. Prologis recently indicated its intention to file redevelopment plans later this year for the Caltrain railyards located at Fourth and King Street. The REIT is proposing a seven-million-square-foot mixed-use project that could accommodate between 1,500 and 4,000 residential units. As reported by the San Francisco Business Times, if fully executed, the development would represent one of the most significant housing initiatives near a major transit corridor in San Francisco. The Business Times noted that the variability in potential housing units offers Prologis the agility to align the project with future demand. Although formal approvals are unlikely before 2027, planning commissioners are already highlighting the importance of affordability. A large logistic facility within the industrial real estate sector. Prologis Vice President Genevieve Cadwalader commented that residential development will be a focal element in the transformation of the railyards into a high-density, transit-oriented urban district. This project holds the potential to be San Francisco's second most densely developed transit-centric neighborhood, following the Transbay district. Prologis, Inc. (NYSE:PLD) is a global REIT focused on high-barrier, high-growth markets in 20 countries. Prologis leases modern logistics facilities to a diverse base of customers across two major categories – business-to-business and retail/online fulfillment. While we acknowledge the potential of PLD as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and . Disclosure. None. Sign in to access your portfolio
Yahoo
14 minutes ago
- Yahoo
JMP Maintains Market Outperform Rating on Whitestone REIT (WSR)
Whitestone REIT (NYSE:WSR) is one of the most undervalued stocks. On June 18, JMP Securities maintained a Market Outperform rating on WSR with a $16 price target, driven by the company's latest Texas acquisition. The firm sees Whitestone's new asset purchase as a strategic move that bolsters its presence in a market with solid fundamentals. The deal aligns with its focus on high-traffic tenants, steady income streams, and mark-to-market opportunities. Whitestone's real estate portfolio currently includes 57 properties concentrated in the Texas and Arizona markets, which JMP mentioned for their robust demographic growth trajectories. The analysts highlight that the company has regularly shown better-than-average performance from these properties. Aerial view of a neighborhood center with many holiday shoppers. JMP praised Whitestone REIT (NYSE:WSR)'s focused expansion in primary markets and its efforts to upgrade asset quality. The firm noted that proceeds from selling underperforming assets at favorable margins are reinvested into higher-return opportunities, driving immediate earnings upside. Analysts pointed out that Whitestone's stock is priced below 12 times its expected 2025 FFO, around two times less than the average for similar REITs. JMP says this is unfair, since Whitestone is growing faster, has better market coverage, and is lowering its debt. Its current ratio of 2.65 shows it has more than enough liquid assets to cover short-term needs. Whitestone REIT (NYSE:WSR) is a community-centric REIT specializing in the acquisition, development, and management of open-air retail centers across high growth US markets, including Phoenix, Austin, Dallas-Fort Worth, Houston, and San Antonio. While we acknowledge the potential of WSR as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and . Disclosure. None.